Cargando…
Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer
BACKGROUND: Although stimuli-responsive nanoplatforms were developed to deliver immunogenic cell death (ICD) inducers to enhance cancer immunotherapy, the complete release of ICD inducers into the tumor microenvironment (TME) was limited by the inadequate supplementation of endogenous stimulus (e.g....
Autores principales: | Wang, Yu, Wang, Qianmei, Wang, Xiaowen, Yao, Pu, Dai, Qing, Qi, Xiaowei, Yang, Ming, Zhang, Xiao, Huang, Rong, Yang, Jing, Wang, Qian, Xia, Peiyuan, Zhang, Dinglin, Sun, Fengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464340/ https://www.ncbi.nlm.nih.gov/pubmed/37608285 http://dx.doi.org/10.1186/s12951-023-02013-y |
Ejemplares similares
-
Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment
por: Wang, Yu, et al.
Publicado: (2021) -
Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy
por: Yao, Pu, et al.
Publicado: (2023) -
Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles
por: Wang, Yu, et al.
Publicado: (2019) -
ROS-Responsive and pH-Sensitive Aminothiols Dual-Prodrug for Radiation Enteritis
por: Chen, Yuanfang, et al.
Publicado: (2022) -
Celastrol Loaded Nanoparticles With ROS-Response and ROS-Inducer for the Treatment of Ovarian Cancer
por: Niu, Weina, et al.
Publicado: (2020)